Fatal disseminated cytomegalovirus infection associated with infliximab and 6-mercaptopurine therapy in a child with Crohn disease.
Pickering
Olufunke
O
Weinstein
Toba
T
Rubin
Lorry G
LG
D000755:Anemia, Sickle Cell / Q000150:complications; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D003587:Cytomegalovirus / Q000187:drug effects / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy; D017809:Fatal Outcome; D015774:Ganciclovir / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab; D015122:Mercaptopurine; D015774:Ganciclovir